PharmD Info

A forum for Indian Pharmacy Professionals

New Drug Information's and other safety information, drug label changes, and Dose and Dosage Calculations, CDCSO,PvPI and FDA Safety Alerts and etc.
  • User avatar
#2602
The preliminary analysis of SUSARs from the PvPI database reveals that the following drugs are
associated with the risks as given below.

Health care professionals, Patients/Consumers are advised to closely monitor the possibility of the above adverse events associated with the use of above drugs. If such events are encountered please report to the NCC-PvPI either by filling of Suspected Adverse Drug Reactions Reporting Form/ Medicines Side Effect Reporting Form for Consumer (http://www.ipc.gov.in) or by PvPI Helpline No. 1800-180-3024.

Drug Safety Alerts

http://www.ipc.gov.in/PvPI/das.html
Similar Topics
Topics Statistics Last post
0 Replies 
1297 Views
by Admin
0 Replies 
508 Views
by Admin
CDER Drug Safety Priorities - 2018
by Admin    - In: Drug Information
0 Replies 
1675 Views
by Admin
0 Replies 
692 Views
by Admin
0 Replies 
538 Views
by Admin

Check Here to get the updates on oncology Phar[…]

When will the new (2022) batch start for fellowshi[…]

Vacancy for the post of Assistant Professor in the[…]

Clinical pharmacist vacancy in Fortis Hospital, Mu[…]

PharmD Info - Highlights